French Biotech Candidate For Cannabis Use Disorder Fails Phase 2B Clinical Trial, Indivior Will Not Exercise Option
French biotechnology company specializing in the treatment of brain disorders Aelis Farma reported Wednesday the results from its clinical Phase 2B trial with AEF0117, evaluating the efficacy and ...
Liz Cheney Says 'I Will Be Voting For Kamala Harris' In 2024 Presidential Election, Cites Trump's Danger To The Republic
Cheney a prominent critic of former President Donald Trump, declared on Wednesday that she will vote for Vice President ...
CBD Increases Effect Of THC, New Study Finds - Quite The Opposite Of Popular Belief
Clinical Pharmacology & Therapeutics that overturns the conventional view, revealing that CBD may actually increase the ...
Bitcoin, Ethereum, Dogecoin Spike As Cryptos Defy Stocks Decline: Analyst Cautions BTC Breakout Traders To Be Wary Of $68K
Major stock indices fell for the second consecutive day. The S&P 500 slipped 8.86 points, or 0.16%, to end at 5,520.07. The tech-focused Nasdaq Composite closed 0.30% lower at 17,084.30. The Dow Jones ...
Microsoft Avoids UK Antitrust Investigation Into Acquisition Of 'Certain Assets' From Inflection AI
The U.K.'s Competition and Markets Authority (CMA) has determined that Microsoft's recruitment of staff from AI firm ...